Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cambridge

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|January 1, 1989
Antibodies to HTLV-I in sera from patients with connective tissue diseasesW Irvine, P White, G Cambridge
Infection and Immunity|January 1, 1976
Cell-mediated immune response to influenza virus infections in miceG Cambridge, J S Mackenzie, D Keast
Clinical and Experimental Immunology|June 1, 1997
Restricted expression of Fc gammaRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis (RA)J C Edwards, S Blades, G Cambridge
Hybridoma|June 1, 1992
Production and characterization of mouse monoclonal antibodies to native human myeloperoxidaseG Cambridge, B Leaker, T J Hall
Clinical and Experimental Immunology|February 5, 1999
A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditionsI C Locke, B Leaker, G Cambridge
British Journal of Rheumatology|February 4, 1998
Anti-MPO in adult- and childhood-onset SLED A Isenberg, L B Tucker, G Cambridge
Immunology|August 14, 1999
Do self-perpetuating B lymphocytes drive human autoimmune disease?J C Edwards, G Cambridge, V M Abrahams
Research Communications in Chemical Pathology and Pharmacology|February 1, 1993
Development of an in vitro hepatotoxicity assay for assessing the effects of chronic drug exposureT J Hall, P R James, G Cambridge
Research Communications in Chemical Pathology and Pharmacology|May 1, 1991
Development of a co-culture system with induced HepG2 cells and K562 cells for examining drug metabolism in vitro. Studies with cyclophosphamide, ondansetron and cisplatinT J Hall, G Cambridge, P R James
Research Communications in Chemical Pathology and Pharmacology|September 1, 1991
Interleukin-2 nephrotoxicity assessed in vitroT J Hall, P R James, G Cambridge
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|January 1, 1989
Antibodies to HTLV-I in sera from patients with connective tissue diseasesW Irvine, P White, G Cambridge
Infection and Immunity|January 1, 1976
Cell-mediated immune response to influenza virus infections in miceG Cambridge, J S Mackenzie, D Keast
Clinical and Experimental Immunology|June 1, 1997
Restricted expression of Fc gammaRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis (RA)J C Edwards, S Blades, G Cambridge
Hybridoma|June 1, 1992
Production and characterization of mouse monoclonal antibodies to native human myeloperoxidaseG Cambridge, B Leaker, T J Hall
Clinical and Experimental Immunology|February 5, 1999
A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditionsI C Locke, B Leaker, G Cambridge
British Journal of Rheumatology|February 4, 1998
Anti-MPO in adult- and childhood-onset SLED A Isenberg, L B Tucker, G Cambridge
Immunology|August 14, 1999
Do self-perpetuating B lymphocytes drive human autoimmune disease?J C Edwards, G Cambridge, V M Abrahams
Research Communications in Chemical Pathology and Pharmacology|February 1, 1993
Development of an in vitro hepatotoxicity assay for assessing the effects of chronic drug exposureT J Hall, P R James, G Cambridge
Research Communications in Chemical Pathology and Pharmacology|May 1, 1991
Development of a co-culture system with induced HepG2 cells and K562 cells for examining drug metabolism in vitro. Studies with cyclophosphamide, ondansetron and cisplatinT J Hall, G Cambridge, P R James
Research Communications in Chemical Pathology and Pharmacology|September 1, 1991
Interleukin-2 nephrotoxicity assessed in vitroT J Hall, P R James, G Cambridge
Pageof 7